Browse by Day Archive
Salmonella outbreak in cucumbers hits 25 states and DC
06/06/2024 10:04pm
The Centers for Disease Control and Prevention says 162 people from 25 states and Washington became sick from salmonella that officials believe might be linked to cucumbers.
'Ransom: Position of Trust': Hilton’s Story
06/06/2024 8:35pm
Late on the night of Saturday, September 16th, 1995 four days after kidnapping McKay, Hilton Crawford drew Sheriff Guy
Trump, in first post-trial rally, demands appeals courts reverse felony conviction
06/06/2024 7:43pm
Donald Trump has returned to the campaign trail with a trip to Arizona, his first appearance in a battleground state since he was convicted in a hush money scandal.
Walmart starts bonus program for hourly workers
06/06/2024 6:17pm
New York (cnn) — Walmart, America’s largest private-sector employer, is starting a bonus program for its hourly
European Union cuts interest rate. Federal Reserve could follow
06/06/2024 5:21pm
For the first time in almost five years, the European Central Bank cut its key interest rate by a quarter percentage point on Thursday, moving from 4.0% to 3.75% in a widely anticipated decision by the bank's governing body.
SpaceX marks first successful Starship test behind Boeing's debut crewed mission
06/06/2024 5:12pm
SpaceX completed a successful test flight of its massive Starship spacecraft on the fourth attempt following a trio of previous flights that ended in fiery destruction.
A new 'Hunger Games' book — and movie — is coming
06/06/2024 4:33pm
Suzanne Collins is returning to the ravaged, post-apocalyptic land of Panem for a new "The Hunger Games" novel. Scholastic announced Thursday that "Sunrise on the Reaping" will be published March 18, 2025.
As AI booms, Microsoft’s deal with a startup comes under federal investigation
06/06/2024 3:39pm
Washington (cnn) — The Federal Trade Commission is investigating a recent Microsoft deal with artificial intelligence
FDA analysis raises no major concerns about Eli Lilly Alzheimer's drug
06/06/2024 3:28pm
An FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on Thursday revealed no red flags, but raised questions about safety of the treatment for patients with early-stage disease.
